Kyntra Bio KYNB
Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001193125-26-216731
- Reports quarterly results (2.02)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Armata Pharmaceuticals ARMP public float $21M, Jun 30, 2025
- Imunon IMNN public float $21M, Jun 30, 2025
- Lunai Bioworks LNAI public float $21M, Dec 31, 2025
- Dare Bioscience DARE public float $21M, Jun 30, 2025
- Aptose Biosciences APTOF public float $22M, Jun 28, 2025